{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:18:38Z","timestamp":1740107918928,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW109-TDU-B-212-114004"],"award-info":[{"award-number":["MOHW109-TDU-B-212-114004"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2321-B-039-002"],"award-info":[{"award-number":["MOST 109-2321-B-039-002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"crossref","award":["DMR-109-126"],"award-info":[{"award-number":["DMR-109-126"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3L0051"],"award-info":[{"award-number":["CMRPG3L0051"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","award":["FEMH-2021-C-051"],"award-info":[{"award-number":["FEMH-2021-C-051"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tseng-Lien Lin Foundation,\u00a0Taichung, Taiwan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00784-021-04175-1","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T05:00:37Z","timestamp":1651122037000},"page":"3843-3852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association between the severity of periodontitis and osteonecrosis of the jaw in patients with different cancer locations: a nationwide population-based study"],"prefix":"10.1007","volume":"26","author":[{"given":"Yi-Fang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Chou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Ta","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsin","family":"Muo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hao","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-791X","authenticated-orcid":false,"given":"Ching-Zong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"4175_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mrfmmm.2008.11.005","volume":"667","author":"D Baldi","year":"2009","unstructured":"Baldi D, Izzotti A, Bonica P, Pera P, Pulliero A (2009) Degenerative periodontal-diseases and oral osteonecrosis: the role of gene-environment interactions. Mutat Res 667:118\u2013131. https:\/\/doi.org\/10.1016\/j.mrfmmm.2008.11.005","journal-title":"Mutat Res"},{"key":"4175_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sandor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J and International Task Force on Osteonecrosis of the J","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sandor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J and International Task Force on Osteonecrosis of the J (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323. https:\/\/doi.org\/10.1002\/jbmr.2405","journal-title":"J Bone Miner Res"},{"key":"4175_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","volume":"16","author":"RA Miksad","year":"2011","unstructured":"Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS (2011) Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 16:121\u2013132. https:\/\/doi.org\/10.1634\/theoncologist.2010-0183","journal-title":"Oncologist"},{"key":"4175_CR4","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1177\/0022034512457373","volume":"91","author":"PI Eke","year":"2012","unstructured":"Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, Surveillance CPD, workgroup: James Beck GDRP (2012) Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 91:914\u2013920. https:\/\/doi.org\/10.1177\/0022034512457373","journal-title":"J Dent Res"},{"key":"4175_CR5","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1002\/jbmr.1669","volume":"27","author":"JI Aguirre","year":"2012","unstructured":"Aguirre JI, Akhter MP, Kimmel DB, Pingel JE, Williams A, Jorgensen M, Kesavalu L, Wronski TJ (2012) Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis. J Bone Miner Res 27:2130\u20132143. https:\/\/doi.org\/10.1002\/jbmr.1669","journal-title":"J Bone Miner Res"},{"key":"4175_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ijos.2014.46","volume":"6","author":"S Pushalkar","year":"2014","unstructured":"Pushalkar S, Li X, Kurago Z, Ramanathapuram LV, Matsumura S, Fleisher KE, Glickman R, Yan W, Li Y, Saxena D (2014) Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw. Int J Oral Sci 6:219\u2013226. https:\/\/doi.org\/10.1038\/ijos.2014.46","journal-title":"Int J Oral Sci"},{"key":"4175_CR7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575. https:\/\/doi.org\/10.1016\/j.joms.2005.07.010","journal-title":"J Oral Maxillofac Surg"},{"key":"4175_CR8","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. Journal of clinical oncology\u202f: official journal of the American Society of Clinical Oncology 27:5356\u20135362. https:\/\/doi.org\/10.1200\/JCO.2009.21.9584","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"4175_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"4175_CR10","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.ijom.2010.04.054","volume":"39","author":"M Kos","year":"2010","unstructured":"Kos M, Brusco D, Kuebler J, Engelke W (2010) Clinical comparison of patients with osteonecrosis of the jaws, with and without a history of bisphosphonates administration. Int J Oral Maxillofac Surg 39:1097\u20131102. https:\/\/doi.org\/10.1016\/j.ijom.2010.04.054","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4175_CR11","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","volume":"41","author":"T Yamazaki","year":"2012","unstructured":"Yamazaki T, Yamori M, Ishizaki T, Asai K, Goto K, Takahashi K, Nakayama T, Bessho K (2012) Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. Int J Oral Maxillofac Surg 41:1397\u20131403. https:\/\/doi.org\/10.1016\/j.ijom.2012.06.020","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4175_CR12","first-page":"39","volume":"31","author":"M Pavkovic","year":"2010","unstructured":"Pavkovic M, Petrushevska G, Jovanovic R, Karanfilski O, Cevreska L, Stankovic S, Stojanovic A (2010) Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates. Prilozi 31:39\u201349","journal-title":"Prilozi"},{"key":"4175_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","volume":"122","author":"V Guarneri","year":"2010","unstructured":"Guarneri V, Miles D, Robert N, Dieras V, Glaspy J, Smith I, Thomssen C, Biganzoli L, Taran T, Conte P (2010) Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast Cancer Res Treat 122:181\u2013188. https:\/\/doi.org\/10.1007\/s10549-010-0866-3","journal-title":"Breast Cancer Res Treat"},{"key":"4175_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/pds.3292","volume":"21","author":"P Tennis","year":"2012","unstructured":"Tennis P, Rothman KJ, Bohn RL, Tan H, Zavras A, Laskarides C, Calingaert B, Anthony MS (2012) Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis. Pharmacoepidemiol Drug Saf 21:810\u2013817. https:\/\/doi.org\/10.1002\/pds.3292","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4175_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00432-014-1853-6","volume":"141","author":"TI Gabbert","year":"2015","unstructured":"Gabbert TI, Hoffmeister B, Felsenberg D (2015) Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients. J Cancer Res Clin Oncol 141:749\u2013758. https:\/\/doi.org\/10.1007\/s00432-014-1853-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"4175_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00784-019-02866-4","volume":"24","author":"YF Huang","year":"2020","unstructured":"Huang YF, Liu SP, Muo CH, Tsai CH, Chang CT (2020) The association between dental therapy timelines and osteoradionecrosis: a nationwide population-based cohort study. Clin Oral Investig 24:455\u2013463. https:\/\/doi.org\/10.1007\/s00784-019-02866-4","journal-title":"Clin Oral Investig"},{"key":"4175_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002348","volume":"95","author":"YF Huang","year":"2016","unstructured":"Huang YF, Chang CT, Liu SP, Muo CH, Tsai CH, Hong HH, Shen YF, Wu CZ (2016) The impact of oral hygiene maintenance on the association between periodontitis and osteoporosis: a nationwide population-based cross sectional study. Medicine (Baltimore) 95:e2348. https:\/\/doi.org\/10.1097\/MD.0000000000002348","journal-title":"Medicine (Baltimore)"},{"key":"4175_CR18","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1210\/jc.2006-2036","volume":"92","author":"M Khamaisi","year":"2007","unstructured":"Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, Elad S (2007) Possible association between diabetes and bisphosphonate-related jaw osteonecrosis. J Clin Endocrinal Metabol 92:1172\u20131175. https:\/\/doi.org\/10.1210\/jc.2006-2036","journal-title":"J Clin Endocrinal Metabol"},{"key":"4175_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120756","volume":"10","author":"YF Huang","year":"2015","unstructured":"Huang YF, Chang CT, Muo CH, Tsai CH, Shen YF, Wu CZ (2015) Impact of bisphosphonate-related osteonecrosis of the jaw on osteoporotic patients after dental extraction: a population-based cohort study. PLoS ONE 10:e0120756. https:\/\/doi.org\/10.1371\/journal.pone.0120756","journal-title":"PLoS ONE"},{"key":"4175_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1592\/phco.28.5.667","volume":"28","author":"AE King","year":"2008","unstructured":"King AE, Umland EM (2008) Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates. Pharmacotherapy 28:667\u2013677. https:\/\/doi.org\/10.1592\/phco.28.5.667","journal-title":"Pharmacotherapy"},{"key":"4175_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","volume":"18","author":"N Yarom","year":"2007","unstructured":"Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S (2007) Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int 18:1363\u20131370. https:\/\/doi.org\/10.1007\/s00198-007-0384-2","journal-title":"Osteoporos Int"},{"key":"4175_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1746-160X-6-11","volume":"6","author":"C Walter","year":"2010","unstructured":"Walter C, Al-Nawas B, Frickhofen N, Gamm H, Beck J, Reinsch L, Blum C, Grotz KA, Wagner W (2010) Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients. Head Face Med 6:11. https:\/\/doi.org\/10.1186\/1746-160X-6-11","journal-title":"Head Face Med"},{"key":"4175_CR23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.14219\/jada.archive.2011.0220","volume":"142","author":"F Francini","year":"2011","unstructured":"Francini F, Pascucci A, Francini E, Miano ST, Bargagli G, Ruggiero G, Petrioli R (2011) Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab. J Am Dent Assoc 142:506\u2013513","journal-title":"J Am Dent Assoc"},{"key":"4175_CR24","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.eururo.2008.06.070","volume":"54","author":"C Walter","year":"2008","unstructured":"Walter C, Al-Nawas B, Grotz KA, Thomas C, Thuroff JW, Zinser V, Gamm H, Beck J, Wagner W (2008) Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 54:1066\u20131072. https:\/\/doi.org\/10.1016\/j.eururo.2008.06.070","journal-title":"Eur Urol"},{"key":"4175_CR25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.oraloncology.2013.06.008","volume":"49","author":"NV Hinchy","year":"2013","unstructured":"Hinchy NV, Jayaprakash V, Rossitto RA, Anders PL, Korff KC, Canallatos P, Sullivan MA (2013) Osteonecrosis of the jaw - prevention and treatment strategies for oral health professionals. Oral Oncol 49:878\u2013886. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.06.008","journal-title":"Oral Oncol"},{"key":"4175_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/path.2078","volume":"211","author":"TL Andersen","year":"2007","unstructured":"Andersen TL, Boissy P, Sondergaard TE, Kupisiewicz K, Plesner T, Rasmussen T, Haaber J, Kolvraa S, Delaisse JM (2007) Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer-host partnership? J Pathol 211:10\u201317. https:\/\/doi.org\/10.1002\/path.2078","journal-title":"J Pathol"},{"key":"4175_CR27","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","volume":"26","author":"A Badros","year":"2008","unstructured":"Badros A, Terpos E, Katodritou E, Goloubeva O, Kastritis E, Verrou E, Zervas K, Baer MR, Meiller T, Dimopoulos MA (2008) Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol Off J Amer Soc Clin Oncol 26:5904\u20135909. https:\/\/doi.org\/10.1200\/JCO.2008.16.9300","journal-title":"J Clin Oncol Off J Amer Soc Clin Oncol"},{"key":"4175_CR28","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","volume":"88","author":"TA Guise","year":"2000","unstructured":"Guise TA (2000) Molecular mechanisms of osteolytic bone metastases. Cancer 88:2892\u20132898","journal-title":"Cancer"},{"key":"4175_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clgc.2014.10.001","volume":"13","author":"P Rodrigues","year":"2015","unstructured":"Rodrigues P, Hering F, Imperio M (2015) Safety of I.v. Nonnitrogen bisphosphonates on the occurrence of osteonecrosis of the jaw: long-term follow-up on prostate cancer patients. Clin Genitourin Cancer 13:199\u2013203. https:\/\/doi.org\/10.1016\/j.clgc.2014.10.001","journal-title":"Clin Genitourin Cancer"},{"key":"4175_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2217\/fon.13.211","volume":"10","author":"G Campisi","year":"2014","unstructured":"Campisi G, Fedele S, Fusco V, Pizzo G, Di Fede O, Bedogni A (2014) Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents. Future Oncol 10:257\u2013275. https:\/\/doi.org\/10.2217\/fon.13.211","journal-title":"Future Oncol"},{"key":"4175_CR31","doi-asserted-by":"publisher","unstructured":"Thorn JJ, Hansen HS, Specht L and Bastholt L (2000) Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg 58:1088\u201393; discussion 1093\u20135. https:\/\/doi.org\/10.1053\/joms.2000.9562","DOI":"10.1053\/joms.2000.9562"},{"key":"4175_CR32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/nejm199602223340802","volume":"334","author":"JR Berenson","year":"1996","unstructured":"Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffernan M, Seaman J, Knight RD (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med 334:488\u2013493. https:\/\/doi.org\/10.1056\/nejm199602223340802","journal-title":"N Engl J Med"},{"key":"4175_CR33","doi-asserted-by":"publisher","unstructured":"Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, Jagannath S, Orlowski RZ, Roodman DG, Twilde P, Anderson K and American Society of Clinical O (2007) American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.\u00a0J Clin Oncol Off J Amer Soc Clin Oncol\u00a025:2464\u20132472. https:\/\/doi.org\/10.1200\/JCO.2007.12.1269","DOI":"10.1200\/JCO.2007.12.1269"},{"key":"4175_CR34","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","volume":"71","author":"C Tsao","year":"2013","unstructured":"Tsao C, Darby I, Ebeling PR, Walsh K, O\u2019Brien-Simpson N, Reynolds E, Borromeo G (2013) Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg 71:1360\u20131366. https:\/\/doi.org\/10.1016\/j.joms.2013.02.016","journal-title":"J Oral Maxillofac Surg"},{"key":"4175_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1902\/jop.2013.130017","volume":"85","author":"V Thumbigere-Math","year":"2014","unstructured":"Thumbigere-Math V, Michalowicz BS, Hodges JS, Tsai ML, Swenson KK, Rockwell L, Gopalakrishnan R (2014) Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J Periodontol 85:226\u2013233. https:\/\/doi.org\/10.1902\/jop.2013.130017","journal-title":"J Periodontol"},{"key":"4175_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1600-051X.1980.tb01960.x","volume":"7","author":"MA Listgarten","year":"1980","unstructured":"Listgarten MA (1980) Periodontal probing: what does it mean? J Clin Periodontol 7:165\u2013176","journal-title":"J Clin Periodontol"},{"key":"4175_CR37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1902\/jop.2000.71.5-S.849","volume":"71","author":"Periodontology TAAo,","year":"2000","unstructured":"Periodontology TAAo, (2000) Parameter on periodontal maintenance. American Academy of Periodontology J Periodontol 71:849\u2013850. https:\/\/doi.org\/10.1902\/jop.2000.71.5-S.849","journal-title":"American Academy of Periodontology J Periodontol"},{"key":"4175_CR38","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1002\/cam4.1221","volume":"6","author":"HY Sroussi","year":"2017","unstructured":"Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS (2017) Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 6:2918\u20132931. https:\/\/doi.org\/10.1002\/cam4.1221","journal-title":"Cancer Med"},{"key":"4175_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10006-012-0363-4","volume":"17","author":"PN Lambade","year":"2013","unstructured":"Lambade PN, Lambade D, Goel M (2013) Osteoradionecrosis of the mandible: a review. Oral Maxillofac Surg 17:243\u2013249. https:\/\/doi.org\/10.1007\/s10006-012-0363-4","journal-title":"Oral Maxillofac Surg"},{"key":"4175_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10006-013-0408-3","volume":"18","author":"M Krimmel","year":"2014","unstructured":"Krimmel M, Ripperger J, Hairass M, Hoefert S, Kluba S, Reinert S (2014) Does dental and oral health influence the development and course of bisphosphonate-related osteonecrosis of the jaws (BRONJ)? Oral Maxillofac Surg 18:213\u2013218. https:\/\/doi.org\/10.1007\/s10006-013-0408-3","journal-title":"Oral Maxillofac Surg"},{"key":"4175_CR41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00520-013-2017-y","volume":"22","author":"SH Lee","year":"2014","unstructured":"Lee SH, Chan RC, Chang SS, Tan YL, Chang KH, Lee MC, Chang HE, Lee CC (2014) Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies. Support Care Cancer 22:553\u2013560. https:\/\/doi.org\/10.1007\/s00520-013-2017-y","journal-title":"Support Care Cancer"},{"key":"4175_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/annonc\/mdr039","volume":"23","author":"AM Vandone","year":"2012","unstructured":"Vandone AM, Donadio M, Mozzati M, Ardine M, Polimeni MA, Beatrice S, Ciuffreda L, Scoletta M (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncology Off J Euro Soc Med Oncol (ESMO) 23:193\u2013200. https:\/\/doi.org\/10.1093\/annonc\/mdr039","journal-title":"Ann Oncology Off J Euro Soc Med Oncol (ESMO)"},{"key":"4175_CR43","first-page":"2477","volume":"34","author":"F Dei","year":"2014","unstructured":"Dei F, Taglieri L, Amoroso L, Vendittozzi S, Blasi L, Salerno G, Lanza R, Scarpa S (2014) Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates. Anticancer Res 34:2477\u20132480","journal-title":"Anticancer Res"},{"key":"4175_CR44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/01.id.0000236120.22719.02","volume":"15","author":"C Scully","year":"2006","unstructured":"Scully C, Madrid C, Bagan J (2006) Dental endosseous implants in patients on bisphosphonate therapy. Implant Dent 15:212\u2013218. https:\/\/doi.org\/10.1097\/01.id.0000236120.22719.02","journal-title":"Implant Dent"},{"key":"4175_CR45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.critrevonc.2006.12.005","volume":"62","author":"R Weitzman","year":"2007","unstructured":"Weitzman R, Sauter N, Eriksen EF, Tarassoff PG, Lacerna LV, Dias R, Altmeyer A, Csermak-Renner K, McGrath L, Lantwicki L, Hohneker JA (2007) Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients\u2013May 2006. Crit Rev Oncol Hematol 62:148\u2013152. https:\/\/doi.org\/10.1016\/j.critrevonc.2006.12.005","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-021-04175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-021-04175-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-021-04175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T10:23:08Z","timestamp":1651746188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-021-04175-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["4175"],"URL":"https:\/\/doi.org\/10.1007\/s00784-021-04175-1","relation":{},"ISSN":["1436-3771"],"issn-type":[{"type":"electronic","value":"1436-3771"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Research Ethics Committee of China Medical University and Hospital, Taiwan, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}